Potential problem? They list the exact problem and call it a potential? The FDA needs to improve their standards and responsibilty's to the american people, that is their purpose. The american people are paying them and trusting them to look out for these dangerous and deadly drugs infiltrating the health care system. The FDA might as well be discontinued and abolished if they can't do their jobs. A rubber stamp government agency is not what we are paying them for. Then doctors must be better informed and educated about these drugs and not rely on drug company claims and misinformation. Side effects are dangerous and more relevant than doctors are led to believe, this is personal experience. I have refused medications because of side affects and its dangers as consumers must learn to do. Consumers bear the final responsibilty of their health and drugs do interfer with consumers ability to be responsible and make choices. Drug companies are dependent on consumers becoming addicted to a lifetime of drugs and profiteering on these hazardous medications. The FDA is in their pockets and helping the rash of life and death altering drugs being distrubted.

the drugs that are approved & put on market for what is called post market trials, really are dangerous, we are the subjects they are tested on, ALL the bone meds,are harming so many of us,the FDA is supposed to review them this yr,there are lots of reports of terrible side effects, from jaw rot to extreme joint & muscle pain, the FDA has not done anything yet, i agree with the post above, the FFDA is helping the drug cos. not the american people.

This list's purpose is to alert heathcare providers and patients of the potential problems/side effects outlined. All medications come with potential risks and benefits. It is the prescibers duty to assure that the patient is aware of the benefits and risks and together they make a decision.
There are three phases of clinical trials that are used to assess the safety and efficacy of medications. These three phases take years to complete. Occasionally the FDA will mandate postmarketing survallence (phase 4) in order to detect rare or long term risks. Additionally the FDA has the MedWatch Program which allows health care professionals to report and monitor side effects and problems.